Franiczek R, Jankowski S
Department of Microbiology, Academy of Medicine, Wrocław, Poland.
Acta Microbiol Pol. 1993;42(3-4):243-50.
About 11% of Escherichia coli strains isolated from patients with urinary tract infections produced capsular antigen K1. In a group of strains resistant to normal human serum the percentage of strains with K1 antigen was higher than that without this antigen. Cefotaxime and serum showed synergistic action in the bactericidal reaction against E. coli strains resistant to the serum. Lack of synergistic effect of thermally inactivated serum with subminimal concentrations of cefotaxime indicated participation of complement in this reaction. The antibiotic used in subminimal concentrations caused significant elongation of E. coli bacilli.
从尿路感染患者中分离出的大肠杆菌菌株约有11%产生荚膜抗原K1。在一组对正常人血清耐药的菌株中,带有K1抗原的菌株百分比高于不带该抗原的菌株。头孢噻肟和血清在针对对血清耐药的大肠杆菌菌株的杀菌反应中显示出协同作用。热灭活血清与亚最小浓度头孢噻肟缺乏协同作用表明补体参与了该反应。亚最小浓度使用的抗生素导致大肠杆菌杆菌显著伸长。